Home » Labopharm’s Antidepressant Drug Gets Generic Threat
Labopharm’s Antidepressant Drug Gets Generic Threat
Canada’s Labopharm Inc said it was notified by Actavis that the generic drugmaker filed with the U.S. health regulator for a copycat version of Labopharm’s antidepressant drug, Oleptro.
CNBC
CNBC
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May